For example, Nbs against prostate-specific membrane antigen (PSMA) for targeting prostate cancer, fibroblast activation protein (FAP) to target cancer-associated fibroblasts or insulin-like growth factor binding protein-7 for the visualization of the neo-vasculature have been described [34]. This evidence concerns the gene FOLH1 and prostate cancer.